Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2003
04/23/2003EP1304160A1 Stabilised mixtures of liposomes and emulsions
04/23/2003EP1304134A1 Auxiliary device for sticking pasting agent
04/23/2003EP1304126A1 Vapour dispensing device
04/23/2003EP1304118A2 Therapeutic uses and formulations for BPI protein products.
04/23/2003EP1304115A1 Antipruritic compositions and compositions promoting wound healing
04/23/2003EP1304109A1 Liquid for oral administration comprising paroxetine
04/23/2003EP1304106A1 FREEZE-DRIED PREPARATION OF N- o-(p-PIVALOYLOXYBENZENESULFONYLAMINO)BENZOYL]GLYCINE MONOSODIUM SALT TETRAHYDRATE AND PROCESS FOR PRODUCING THE SAME
04/23/2003EP1304105A2 Diffusional implantable delivery system
04/23/2003EP1304104A2 Tablet comprising a phosphate-binding polymer
04/23/2003EP1304103A1 New non-phospholipid lipid vesicles (npLV) and their use in cosmetic, therapeutic and prophylactic applications
04/23/2003EP1303541A1 Gel compositions containing metronidazole
04/23/2003EP1303387A1 Method of producing structures using centrifugal forces
04/23/2003EP1303309A1 Rapidly-disintegrating tablets for animals
04/23/2003EP1303301A2 Preventing airway mucus production by administration of egf-r antagonists
04/23/2003EP1303298A2 Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase
04/23/2003EP1303297A2 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency
04/23/2003EP1303283A2 Treatment of hyperproliferative skin disorders and diseases
04/23/2003EP1303278A1 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states
04/23/2003EP1303277A1 Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence
04/23/2003EP1303276A1 A bioavailable dosage form of loratadine
04/23/2003EP1303275A2 Paroxetine tablets and capsules
04/23/2003EP1303273A1 New pharmaceutical composition and the process for its preparation
04/23/2003EP1303271A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
04/23/2003EP1303267A1 Dermal for amino laevulinic acid
04/23/2003EP1303262A2 Use of a spla2 inhibitor for the treatment of sepsis
04/23/2003EP1303261A2 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
04/23/2003EP1303260A2 Linkage of agents using microparticles
04/23/2003EP1303259A1 Prolonged release microspheres for injection delivery and preparation method
04/23/2003EP1303258A1 Novel aerosol formulation containing a polar fluorinated molecule
04/23/2003EP1303257A1 Pharmaceutical extemporary compositions
04/23/2003EP1303249A1 Antimycotic nail varnish composition
04/23/2003EP1257537A4 Therapeutic morpholino-substituted compounds
04/23/2003EP1242009A4 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds
04/23/2003EP1146862B1 Pharmaceutical compositions
04/23/2003EP1135397B1 Method for preparation of disodium pamidronate
04/23/2003EP1131072B1 Pharmaceutical combination preparations in solid dosage form of carvedilol and hydrochlorothiazide
04/23/2003EP1131063B1 Hyperforin ointment or cream
04/23/2003EP1121102B1 Liposome-entrapped topoisomerase inhibitors
04/23/2003EP1105109B1 Injectable formulations of nanoparticulate naproxen
04/23/2003EP1047406B1 Autoclavable pharmaceutical compositions containing a chelating agent
04/23/2003EP1030689B1 Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions
04/23/2003EP1017363B1 Taste masking for unpalatable formulations
04/23/2003EP1007100B1 Improvements in or relating to contrast agents in ultrasound imaging
04/23/2003EP0941085B1 Device for electrically assisted delivery of agents such as lidocaine and epinephrine
04/23/2003EP0910412B1 Hydrolysable hydrogels for controlled release
04/23/2003EP0910379B1 Plaster for the transdermal application of pergolide
04/23/2003EP0863762A4 Methods of production and use of liquid formulations of plasma proteins
04/23/2003EP0859599B1 Liposomal formulations of mitoxantrone
04/23/2003EP0831825B1 Pharmaceutical formulations of highly lipophilic camptothecin derivatives
04/23/2003EP0804150B1 Lotions containing fatty acid derivatives
04/23/2003EP0797443B1 A pharmaceutical composition with improved bio-availability of inositol phosphate
04/23/2003EP0788373B1 Novel complexes of taxol or taxotere and pharmaceutical compositions
04/23/2003EP0763982B1 Novel bioemulsifiers
04/23/2003CN1413241A Dry compositions containing hydrophobic amino acid
04/23/2003CN1413125A Sensitive substance encapsulation
04/23/2003CN1413118A Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof
04/23/2003CN1413117A Drugs, drinks or foods
04/23/2003CN1413116A Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract
04/23/2003CN1413114A System for stabilizing lacrimal fluid layer
04/23/2003CN1413113A Method of treating gastrointestinal tract disease using purinergic receptor agonists
04/23/2003CN1413112A Nasal drops containing fused pyridazine derivatives
04/23/2003CN1413110A Pharmaceutical composition
04/23/2003CN1413104A New (aminopropyl) methylphosphinic acids
04/23/2003CN1413100A Local prevention or amelioration of pain from surgically closed wounds
04/23/2003CN1411870A Acupoint plaster and its application
04/23/2003CN1411859A Chinese medicine plaster for curing diseases of digestive, respiratory and circulatory systems and its preparation process
04/23/2003CN1411851A Chinese adhesive plaster for curing rheumatism and hyperosteogeny
04/23/2003CN1411844A Weight-reducing Chinese medicine acted on acupoint
04/23/2003CN1411841A Chinese medicine plaster for external application for curing hyperosteogeny, cervical spondylopathy and prolapse of lumbar intervertebral disk and its preparation method
04/23/2003CN1411831A Borneol toad pain-stopping adhesive plaster and its preparation method
04/23/2003CN1411830A Medicine for curing hypertension and its preparation method
04/23/2003CN1411827A Capsule for curing acne
04/23/2003CN1411824A Biological pourpoint depression and nano concentration process for extracting aloe juice
04/23/2003CN1411805A Biological medicine film and its preparation method
04/23/2003CN1411804A Film forming composition containing sucralose
04/23/2003CN1411803A Method for preparing precursor liposome and its device
04/23/2003CN1411802A Liquid preparation for external application for broad-spectrum sterilization and resisting herpes simplex virus
04/23/2003CN1106379C 2-propyl valeramide and 2-propyl valeramide derivative and medical use as anticonvulsants
04/23/2003CN1106270C Multi-action particle for structuring biological media
04/23/2003CN1106214C Method and equipment for preparing air-containing vesicles
04/23/2003CN1106198C Production process of biological active woodfrog fat capsule
04/23/2003CN1106194C 组合物 The composition
04/23/2003CN1106192C Oil in water emulsions containing 2,6,-diisopropyl phenic and ehtylenedinamine-tetraacetic salt
04/23/2003CN1106191C Methyl-naphthyl-oxythiophene-propyl amine enteric pellets
04/22/2003US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof
04/22/2003US6552172 Forming water in oil emulsion of fibrinogen, thrombin and factor XIII, homogenizing and isolating
04/22/2003US6552142 Free-radical polymerization of ethylenically unsaturated monomers in an aqueous medium comprising hydrophilic monomer A which has and N-vinyl group and monoethylenically unsaturated hydrophobic monomer and free-radical initiator
04/22/2003US6552082 Solubility makes it possible to manufacture a solution of higher concentration of the compound and high-dosage drug product
04/22/2003US6552063 Veterinary medicine
04/22/2003US6552050 Method for enhancing protective cellular responses to genotoxic stress in skin
04/22/2003US6552031 Synergistic analgesic combination of oxycodone and rofecoxib
04/22/2003US6552024 For administering agents in a dissolving film configuration; drug delivery
04/22/2003US6552010 Treatment of SLE with dehydroepiandrosterone
04/22/2003US6552004 Delivery system for entrapping charged macromolecules and a method for preparing same
04/22/2003US6552002 Miticides, parasiticides; veterinary medicine
04/22/2003US6551996 Super-active porcine growth hormone releasing hormone analog
04/22/2003US6551995 For allogenic or xenogenic implants and which act as a carrier of the osteogenic protein to induce new bone formation in mammals
04/22/2003US6551992 Stable insulin formulations
04/22/2003US6551989 Preventing airway mucus production by administration of EGF-R antagonists
04/22/2003US6551838 Microfabricated devices for the storage and selective exposure of chemicals and devices
1 ... 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 ... 2991